10x Genomics ROA 2018-2024 | TXG

Current and historical return on assets (ROA) values for 10x Genomics (TXG) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
10x Genomics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2024-09-30 $-0.18B $0.94B -19.49%
2024-06-30 $-0.24B $0.93B -25.48%
2024-03-31 $-0.26B $0.92B -27.59%
2023-12-31 $-0.26B $0.97B -26.03%
2023-09-30 $-0.22B $0.95B -22.40%
2023-06-30 $-0.17B $0.99B -17.08%
2023-03-31 $-0.17B $1.01B -17.22%
2022-12-31 $-0.17B $1.03B -16.38%
2022-09-30 $-0.17B $1.00B -16.52%
2022-06-30 $-0.14B $1.00B -14.05%
2022-03-31 $-0.09B $1.00B -8.82%
2021-12-31 $-0.06B $1.02B -5.89%
2021-09-30 $-0.46B $0.99B -47.35%
2021-06-30 $-0.51B $0.98B -51.74%
2021-03-31 $-0.53B $0.95B -60.87%
2020-12-31 $-0.54B $0.93B -68.63%
2020-09-30 $-0.13B $1.04B -18.86%
2020-06-30 $-0.08B $0.58B -17.34%
2020-03-31 $-0.05B $0.61B -16.12%
2019-12-31 $-0.03B $0.61B -21.12%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.732B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Movano (MOVE) United States $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00